SEC 13F Intelligence

Nextbio Capital Management LP / CMPX

Nextbio Capital Management LP’s Compass Therapeutics Inc Position

Does Nextbio Capital Management LP own Compass Therapeutics Inc (CMPX)? Yes848.2K shares worth $4M (+2.08% of its 13F portfolio) as of Q1 2026, down from 1.11M shares the prior filed quarter.

Position Value
$4M
Q1 2026
Shares
848.2K
% of Portfolio
+2.08%
Quarters Held
2
currently held

Position History CMPX

Reported value by quarter
Q4 ’25: $6MQ4 ’25Q1 ’26: $4MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026848.2K$4M+2.08%
Q4 20251.11M$6M+3.51%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Nextbio Capital Management LP’s full portfolio or all institutional holders of CMPX.